Appleton Group’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$356K Hold
4,878
1.24% 14
2023
Q2
$308K Buy
+4,878
New +$283K 0.43% 21
2022
Q4
Sell
-4,187
Closed -$281K 44
2022
Q3
$281K Buy
4,187
+15
+0.4% +$949 0.8% 20
2022
Q2
$256K Sell
4,172
-3,241
-44% -$208K 1.49% 23
2022
Q1
$500K Buy
+7,413
New +$400K 0.7% 15
2021
Q4
Sell
-5,566
Closed -$360K 55
2021
Q3
$360K Buy
5,566
+212
+4% +$14.7K 0.31% 32
2021
Q2
$431K Buy
5,354
+1,349
+34% +$103K 0.33% 24
2021
Q1
$272K Buy
+4,005
New +$315K 0.36% 41

Other funds holding HQY

Appleton Group's HQY Position: Q3 2023 in Review

Appleton Group held its HealthEquity (HQY) position steady in Q3 2023 at 4,878 shares worth $356K. The position accounts for 1.24% of the portfolio, ranked #14.

Appleton Group first reported a position in HQY in Q1 2021 and has held it in 8 quarters since. The position peaked at $500K in Q1 2022. 342 funds tracked by Wall St. Rank hold HQY as of Q3 2023.

  • Appleton Group held 4,878 shares of HealthEquity worth $356K as of Q3 2023.
  • Appleton Group left its HealthEquity share count unchanged in Q3 2023.
  • HealthEquity made up 1.24% of Appleton Group's portfolio in Q3 2023, its #14 holding.
  • Appleton Group first reported a position in HealthEquity in Q1 2021 and has held it in 8 quarters since.
  • Appleton Group's HealthEquity position peaked at $500K in Q1 2022.
  • 342 funds tracked by Wall St. Rank held HealthEquity as of Q3 2023.

Based on Appleton Group's 13F filing for Q3 2023, filed 8 Nov 2023.